New guidelines to evaluate the response to treatment in solid tumors
European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. doi:10.1093/jnci/92.3.205. PMid:10655437
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216. doi:10.1093/jnci/92.3.205. PMid:10655437.
Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): Recommendations of the German GIST Imaging Working Group
PMid:22572545
Kalkmann J, Zeile M, Antoch G, et al. Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group. Cancer Imaging 2012; 12: 126-135. PMid:22572545.
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
doi:10.1200/JCO.2006.07.3049. PMid:17470865
Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 2007; 25: 1753-1759. doi:10.1200/JCO.2006.07.3049. PMid:17470865.
Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomography
doi:10.1102/1470-7330.2011.0015. PMid:21771709
Bethke A, Kühne K, Platzek I, Stroszczynski C. Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomography. Cancer Imaging 2011; 11: 91-99. doi:10.1102/1470-7330. 2011.0015. PMid:21771709.
Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab
doi:10.1102/1470-7330.2012.0027. PMid:22743083
Nishino M, Cryer SK, Okajima Y, et al. Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab. Cancer Imaging 2012; 12: 225-235. doi:10.1102/1470-7330.2012.0027. PMid:22743083.